AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « pathogenesis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
pathogeneses < pathogenesis < pathogenetic  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 62.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000031 (2005) Shumpei Yokota [Japon] ; Takako Miyamae [Japon] ; Tomoyuki Imagawa [Japon] ; Shigeki Katakura [Japon] ; Rumiko Kurosawa [Japon] ; Masaaki Mori [Japon]Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
000044 (2010) Yoh Arita [Japon] ; Yasushi Sakata [Japon] ; Takao Sudo [Japon] ; Tetsuo Maeda [Japon] ; Ken Matsuoka [Japon] ; Keito Tamai [Japon] ; Kaori Higuchi [Japon] ; Wataru Shioyama [Japon] ; Yoshikazu Nakaoka [Japon] ; Yuzuru Kanakura [Japon] ; Keiko Yamauchi-Takihara [Japon]The efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman’s disease
000058 (2014) Lucie M. Turcotte [États-Unis] ; Colleen K. Correll ; Robyn C. Reed ; Christopher L. MoertelSustained remission of severe multicentric castleman disease following multiagent chemotherapy and tocilizumab maintenance
000122 (2006) C. Christodoulou [Royaume-Uni] ; E. H. Choy [Royaume-Uni]Joint inflammation and cytokine inhibition in rheumatoid arthritis
000143 (2012) Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France]Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
000151 (2012) I. Kötter [Allemagne]Update Morbus Behçet
000153 (2013) Akiyuki Uzawa [Japon] ; Masahiro Mori [Japon] ; Satoshi Kuwabara [Japon]Role of interleukin‐6 in the pathogenesis of neuromyelitis optica
000173 (2013) Nam Trung Nguyen [Japon, Viêt Nam] ; Taisuke Nakahama [Japon] ; Tadamitsu Kishimoto [Japon]Aryl hydrocarbon receptor and experimental autoimmune arthritis
000179 (2009) Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu KishimotoEvidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody
000195 (2010) Luciana Breda [Italie] ; Marianna Del Torto [Italie] ; Sara De Sanctis [Italie] ; Francesco Chiarelli [Italie]Biologics in children’s autoimmune disorders: efficacy and safety
000196 (2008) Y. Shirota [États-Unis] ; Gg Illei [États-Unis] ; Np Nikolov [États-Unis]Biologic treatments for systemic rheumatic diseases
000246 (2011) Bernard Bannwarth [France]Prise en charge thérapeutique de l’inflammation d’origine rhumatismale
000256 (2012) Tsuyoshi Kasama [Japon] ; Hidekazu Furuya [Japon] ; Ryo Yanai [Japon] ; Kumiko Ohtsuka [Japon] ; Ryo Takahashi [Japon] ; Nobuyuki Yajima [Japon] ; Yusuke Miwa [Japon] ; Kazuo Kobayashi [Japon]Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome
000283 (2011) A. Arman [Turquie] ; A. Coker [Turquie] ; O. Sarioz [Turquie] ; N. Inanc [Turquie] ; H. Direskeneli [Turquie]Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population
000290 (2011) Yiyun Yu [États-Unis, République populaire de Chine] ; Antonio La Cava [États-Unis]Current drugs in systemic lupus erythematosus
000325 (2013) Desmond Yat Hin Yap ; Kar Neng Lai [Hong Kong]The role of cytokines in the pathogenesis of systemic lupus erythematosus – from bench to bedside
000464 (2009) T. Pap [Allemagne]Aktuelle Trends in Design und Entwicklung monoklonaler Antikörper gegen Entzündungsmediatoren zur Therapie der rheumatoiden Arthritis
000512 (2010) Aharon Kessel [Israël] ; Regina Peri [Israël] ; Tharwat Haj [Israël] ; Ayelet Snir [Israël] ; Gleb Slobodin [Israël] ; Edmond Sabo [Israël] ; Itzhak Rosner [Israël] ; Yehuda Shoenfeld [Israël] ; Elias Toubi [Israël]IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients
000537 (2012) Rita A. Moura [Portugal] ; Luis Graca [Portugal] ; João E. Fonseca [Portugal]To B or Not to B the Conductor of Rheumatoid Arthritis Orchestra
000590 (2013) Benjamin Terrier [France] ; Luc Mouthon [France]Lupus érythémateux systémique
000683 (2013) David Jayne [Royaume-Uni]New-generation therapy for ANCA-associated vasculitis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "pathogenesis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "pathogenesis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    pathogenesis
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021